A Window of Opportunity Study for Investigating Drug Tolerant Persister (DTP) to Neoadjuvant Osimertinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harbouring EGFR Mutations
Clinical trial NCT04816838 · UNKNOWN
Trial details
- NCT number
- NCT04816838
- Sponsor
- Yonsei University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-10
- Primary completion
- 2025-07-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.